Showing results (3141-3150 of 3,662) with videos related to

Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|March 1, 2020
"Three-dimensional evaluation of breast volume changes following autologous free flap breast reconstruction over six months"Floor N H Wilting, Marijn Hameeteman, Hanneke J P Tielemans, et al.
Breast (Edinburgh, Scotland)|March 21, 2020
Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot studyTeresa M Salgado, Jin Liu, Holly L Reed, et al.
Breast (Edinburgh, Scotland)|March 22, 2020
Evaluation of 2014 margin guidelines on re-excision and recurrence rates after breast conserving surgery: A multi-institution retrospective studyAnne Kuritzky, Chantal Reyna, Kandace P McGuire, et al.
Breast (Edinburgh, Scotland)|March 3, 2020
The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic reviewSena Alaeikhanehshir, Ellen G Engelhardt, Frederieke H van Duijnhoven, et al.
Breast (Edinburgh, Scotland)|February 1, 2019
The impact of the 21-gene recurrence score (Oncotype DX) on concordance of adjuvant therapy decision making as measured by the Liverpool Systemic Therapy Adjuvant Decision ToolAnna Olsson-Brown, Pavlos Piskilidis, Julie O'Hagan, et al.
Breast (Edinburgh, Scotland)|November 3, 2019
The ethical, legal and social implications of using artificial intelligence systems in breast cancer careStacy M Carter, Wendy Rogers, Khin Than Win, et al.
Breast (Edinburgh, Scotland)|December 2, 2019
Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test resultsAurelia Noske, Sophie-Isabelle Anders, Johannes Ettl, et al.
Breast (Edinburgh, Scotland)|December 2, 2019
Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American womenKimberly A Bertrand, Traci N Bethea, Lynn Rosenberg, et al.
Breast (Edinburgh, Scotland)|February 17, 2020
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUTGuenther G Steger, Daniel Egle, Rupert Bartsch, et al.
Breast (Edinburgh, Scotland)|January 15, 2020
Artificial intelligence in digital breast pathology: Techniques and applicationsAsmaa Ibrahim, Paul Gamble, Ronnachai Jaroensri, et al.
Pageof 367